NGNE Neurogene PE ratio, current and historical analysis
The PE ratio for Neurogene stock stands at 0.48 as of Mar 20, 2025. This is calculated based on the TTM EPS of $31.92 and the stock price of $15.23 per share.
NGNE PE ratio history
Neurogene PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 0.7 | N/A | $19.38 | $27.76 |
| 2022 | N/A | N/A | $10.18 | -$139.88 |
| 2021 | N/A | N/A | $96.4 | -$22 |
| 2020 | N/A | N/A | $282 | -$12.8 |
| 2019 | N/A | N/A | $246.4 | -$51.4 |
| 2018 | N/A | N/A | $43.2 | -$26.8 |
| 2017 | N/A | N/A | $235.2 | -$42.8 |
| 2016 | N/A | N/A | $330.2 | -$39.2 |
| 2015 | N/A | N/A | $249.6 | -$34.6 |
| 2014 | N/A | N/A | $150 | -$55 |
| 2013 | N/A | N/A | N/A | -$990.4 |
| 2012 | N/A | N/A | N/A | -$804.6 |
Neurogene PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 1.31 | -98.42% | $41.96 | $31.92 |
| Jun 2024 | 82.7 | N/A | $36.39 | $0.44 |
| Mar 2024 | N/A | N/A | $50.9 | -$25.15 |
| Dec 2023 | 0.7 | N/A | $19.38 | $27.76 |
| Sep 2023 | N/A | N/A | $15.8 | -$211.55 |
| Jun 2023 | N/A | N/A | $16.6 | -$183.6 |
| Mar 2023 | N/A | N/A | $14 | -$162.52 |
| Dec 2022 | N/A | N/A | $10.18 | -$139.88 |
| Sep 2022 | N/A | N/A | $12.8 | -$21.32 |
| Jun 2022 | N/A | N/A | $20.6 | -$22.2 |
| Mar 2022 | N/A | N/A | $37.6 | -$22 |
| Dec 2021 | N/A | N/A | $96.4 | -$22 |
| Sep 2021 | N/A | N/A | $144.6 | -$21 |
| Jun 2021 | N/A | N/A | $184.6 | -$16.2 |
| Mar 2021 | N/A | N/A | $246.2 | -$14.8 |
NGNE average PE ratio chart
NGNE PE vs peers
In comparison to its peer stock ORMP, NGNE's PE ratio is lower.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NGNE Neurogene Inc | 0.44 | $209.75M |
| ORMP Oramed Pharmaceuticals Inc | 21.45 | $95.14M |
| OLMA Olema Pharmaceuticals Inc | N/A | $282.22M |
| OMER Omeros Corp | N/A | $533.14M |
| ONVO Organovo Holdings Inc | N/A | $54.98M |
| ORIC Oric Pharmaceuticals Inc | N/A | $501.45M |
Frequently asked questions
What is Neurogene's PE ratio?
NGNE's price to earnings ratio is 0.48 as of Mar 20, 2025.
Why is Neurogene's PE ratio so low?
NGNE's PE ratio is low because its earnings per share (EPS) is high relative to its stock price.
How is NGNE's PE ratio calculated (Neurogene PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Mar 20, 2025), Neurogene's share price is $15.23. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $31.92. Therefore, Neurogene's PE ratio for today is 0.48. PE RATIO(0.48) = STOCK PRICE($15.23) / TTM EPS($31.92)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.